GB0500056D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB0500056D0
GB0500056D0 GB0500056A GB0500056A GB0500056D0 GB 0500056 D0 GB0500056 D0 GB 0500056D0 GB 0500056 A GB0500056 A GB 0500056A GB 0500056 A GB0500056 A GB 0500056A GB 0500056 D0 GB0500056 D0 GB 0500056D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0500056A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0500056A priority Critical patent/GB0500056D0/en
Publication of GB0500056D0 publication Critical patent/GB0500056D0/en
Priority to MXPA06013540A priority patent/MXPA06013540A/en
Priority to EP05746284A priority patent/EP1753753A1/en
Priority to US11/569,150 priority patent/US20070208062A1/en
Priority to JP2007514091A priority patent/JP2008500319A/en
Priority to BRPI0511535-3A priority patent/BRPI0511535A/en
Priority to CA002567457A priority patent/CA2567457A1/en
Priority to AU2005247671A priority patent/AU2005247671A1/en
Priority to PCT/GB2005/002059 priority patent/WO2005116024A1/en
Priority to IL179346A priority patent/IL179346A0/en
Priority to NO20065873A priority patent/NO20065873L/en
Ceased legal-status Critical Current

Links

GB0500056A 2004-05-25 2005-01-05 Chemical compounds Ceased GB0500056D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB0500056A GB0500056D0 (en) 2005-01-05 2005-01-05 Chemical compounds
PCT/GB2005/002059 WO2005116024A1 (en) 2004-05-25 2005-05-24 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
JP2007514091A JP2008500319A (en) 2004-05-25 2005-05-24 3- (4- (2-Dihydroisoxazol-3-ylpyridin-5-yl) phenyl-5-triazol-1-ylmethyloxazolidin-2-one derivatives as MAO inhibitors for the treatment of bacterial infections
EP05746284A EP1753753A1 (en) 2004-05-25 2005-05-24 3-(4-(2-dihydroisoxazol-3-ylpyrdin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
US11/569,150 US20070208062A1 (en) 2004-05-25 2005-05-24 3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
MXPA06013540A MXPA06013540A (en) 2004-05-25 2005-05-24 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections.
BRPI0511535-3A BRPI0511535A (en) 2004-05-25 2005-05-24 compound or a pharmaceutically acceptable salt thereof, or prodrug thereof, prodrug, method for producing an antibacterial effect on a warm-blooded animal, use of a compound or a pharmaceutically acceptable salt, or hydrolyzable ester or an in vivo hydrolysable ester thereof, pharmaceutical composition, and process for the preparation of a compound or pharmaceutically acceptable salts or in vivo hydrolysable esters thereof
CA002567457A CA2567457A1 (en) 2004-05-25 2005-05-24 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
AU2005247671A AU2005247671A1 (en) 2004-05-25 2005-05-24 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as MAO inhibitors for the treatment of bacterial infections
IL179346A IL179346A0 (en) 2004-05-25 2006-11-16 3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
NO20065873A NO20065873L (en) 2004-05-25 2006-12-19 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxoazolidin-2-one derivatives as MAO inhibitors in the treatment of bacterial infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0500056A GB0500056D0 (en) 2005-01-05 2005-01-05 Chemical compounds

Publications (1)

Publication Number Publication Date
GB0500056D0 true GB0500056D0 (en) 2005-02-09

Family

ID=34179152

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0500056A Ceased GB0500056D0 (en) 2004-05-25 2005-01-05 Chemical compounds

Country Status (1)

Country Link
GB (1) GB0500056D0 (en)

Similar Documents

Publication Publication Date Title
GB0504753D0 (en) Chemical compounds
GB0503056D0 (en) Chemical compounds
GB0511266D0 (en) Chemical compounds
GB0514018D0 (en) Chemical compounds
EP1951217A4 (en) Chemical compounds
EP1951250A4 (en) Chemical compounds
EP1919872A4 (en) Chemical compounds
GB0503053D0 (en) Chemical compounds
EP1853604A4 (en) Chemical compounds
EP1940394A4 (en) Chemical compounds
EP1959737A4 (en) Chemical compounds
EP1948187A4 (en) Chemical compounds
EP1896014A4 (en) Chemical compounds
GB0503054D0 (en) Chemical compounds
GB0510852D0 (en) Chemical compounds
GB0504475D0 (en) Chemical compounds
GB0504474D0 (en) Chemical compounds
GB0514017D0 (en) Chemical compounds
GB0507200D0 (en) Chemical compounds
GB0506886D0 (en) Chemical compounds
GB0500301D0 (en) Chemical compounds
GB0514174D0 (en) Chemical compounds
GB0511851D0 (en) Chemical compounds
GB0514173D0 (en) Chemical compounds
GB0507347D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)